Document Detail


Safety and toxicity of oxamniquine in the treatment of Schistosoma mansoni infections, with particular reference to electroencephalographic abnormalities.
MedLine Citation:
PMID:  6650735     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirty-seven patients infected with Schistosoma mansoni were treated with oxamniquine. All were cured. The only significant adverse reaction was the development of abnormal electroencephalographic (EEG) findings in 6 (17.6%) of 34 patients whose pretreatment EEG was normal. Management of patients, with particular reference to the EEG abnormalities, is discussed.
Authors:
S Krajden; J S Keystone; C Glenn
Related Documents :
56435 - Late effects of brain biopsy.
14568485 - Using patient-specific hemodynamic response functions in combined eeg-fmri studies in e...
15721085 - Disturbed fluctuations of resting state eeg synchronization in alzheimer's disease.
8800935 - Clinical and physiological features of epilepsia partialis continua. cases ascertained ...
434675 - Persistence of neutrophil hypersegmentation during recovery from megaloblastic granulop...
17412645 - Different clinical manifestations of hyperammonemic encephalopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of tropical medicine and hygiene     Volume:  32     ISSN:  0002-9637     ISO Abbreviation:  Am. J. Trop. Med. Hyg.     Publication Date:  1983 Nov 
Date Detail:
Created Date:  1984-01-26     Completed Date:  1984-01-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370507     Medline TA:  Am J Trop Med Hyg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1344-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Drug Evaluation
Electroencephalography*
Female
Humans
Male
Middle Aged
Nitroquinolines / adverse effects*
Oxamniquine / adverse effects*
Schistosoma mansoni
Schistosomiasis / drug therapy*
Chemical
Reg. No./Substance:
0/Nitroquinolines; 21738-42-1/Oxamniquine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship of prevalence and intensity of infection to morbidity in schistosomiasis japonica: a st...
Next Document:  Amoscanate as a topically applied chemical for prophylaxis against Schistosoma mansoni infections in...